Iovance Biotherapeutics is dedicated to the fight against cancer.
Joined February 2020
- Tweets 355
- Following 106
- Followers 2,304
- Likes 132
207 Photos and videos
At lovance, cancer survivors are at the heart of everything we do. Today, we celebrate the strength, resilience, and determination of those who continue to inspire our mission to advance new possibilities for people living with cancer. #NationalCancerSurvivorsDay
8
56
2,604
What a week. From #ASCO26 to the Jefferies Healthcare Conference — and two exciting milestones in between:
✅ IND clearance for IOV-5001
✅ Regulatory approval in Australia
Proud to be advancing TIL cell therapy for patients who need it most. 🔗iovance.com
8
57
7,756
Today Fred Vogt, PhD, and Corleen Roche will participate in a fireside chat at the Jefferies Global Healthcare Conference at 1:25 p.m. ET. Register for the live webcast or replay here: ir.iovance.com/events/event-…
2
26
9,310
AMTAGVI® (lifileucel) is now TGA-approved in Australia for advanced melanoma — a first-of-its-kind T cell therapy for a solid tumor cancer. Full press release here: ir.iovance.com/news-events/p…
10
51
16,617
Visit us at Booth #13119! 🦈
May 31
ASCO 2026 is full of landmark science - but let’s be honest, the exhibit hall also runs on coffee, snacks, and smart booth detours. ☕🍪
The OncoDaily team explored the McCormick Place exhibit floor and put together a lighthearted booth-by-booth guide to some of the best food stops at this year’s meeting. 🍽️✨
From smoothies and pretzels to marshmallow lattes, ice cream, cookies, and even a Chicago-style hot dog moment — sometimes the right snack is exactly what you need between sessions. 🌭🍦🥨
Science first, always. But a good conference snack route definitely helps. 🧬
Read the full OncoDaily guide and tell us: which ASCO booth food stop was your favorite? 👇
oncodaily.com/opinion/best-f…
@AstellasUS @ConcertAI @IovanceBio
11
1,163
Iovance Biotherapeutics Announces Clearance of Investigational New Drug (IND) Application for IL-12 Tethered TIL Therapy IOV-5001 ir.iovance.com/news-releases…
6
28
4,440
lovance will present 2 posters today at #ASCO26 featuring ongoing research in cell therapy and solid tumors. Learn more below:
5
30
1,820
We are attending the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. Stop by our booth to connect with our team and learn more about our ongoing work in cell therapy. #ASCO26
3
5
36
2,887
This #InternationalClinicalTrialsDay, we're celebrating the patients, clinicians, and researchers whose courage and commitment drive progress forward, and bring us closer to delivering innovative treatments with urgency. Read more: iovance.com/clinical-pipelin…
4
24
1,441
Last week, we welcomed patients living with rare melanomas and their families to iCTC for #MelanomaAwarenessMonth. We are deeply grateful to them for sharing their stories.
1
21
595
Today Iovance reported first quarter 2026 financial results and corporate updates. We will host an audio webcast at 8:30 am ET today, join live or listen to the replay: ir.iovance.com/news-events/e…
1
3
15
1,105
This Melanoma Monday, we recognize the urgency to advance progress for those impacted by melanoma. As Brian Gastman, M.D., shares, we remain committed to meaningful impact for patients and their families, because patients can’t wait.
5
3
20
4,628
On May 6, Arvind Natarajan, SVP Technical Development at Iovance, will join Friends of Cancer Research and Parker Institute for Cancer Immunotherapy to discuss how smarter, more flexible approaches can help move innovation forward: friendsofcancerresearch.org/…
2
18
1,639
This past weekend, Iovance proudly supported @AIMatMelanoma #StepsAgainstMelanoma in Birmingham, AL to celebrate the power of community and shared purpose to drive research forward.
8
507
Our team attended the inaugural Melanoma US Focus Meeting last week, reinforcing our commitment to patients with #AdvancedMelanoma. Discussions with partners and experts highlighted continued progress. We’re proud of Iovance’s role in advancing new possibilities for patients.
5
3
29
1,963
Today at the SITC Spring Scientific meeting, EVP of Translational Medicine & Research, Brian Gastman, will present preclinical data for IOV-5001, a next generation, genetically engineered TIL therapy: iovance.com/scientific-publi…
6
5
38
8,956
#MucosalMelanoma represents ~1% of melanoma diagnoses and is often found in “hidden” areas, leading to delayed diagnosis. Raising awareness can help people recognize symptoms sooner and connect with trusted resources. At Iovance, we are committed to supporting this community.
3
4
16
1,089
Our EVP of Translational Medicine & Research, Brian Gastman, and Head of Investor Relations and Corporate Communications, Sara Pellegrino, will participate in a fireside chat at the Barclays 28th Annual Healthcare Conference today. Register here: ir.iovance.com/events/event-…
1
2
14
2,874
Iovance CFO Corleen Roche and COO Igor Bilinsky will participate in a presentation and fireside chat at the TD Cowen 46th Annual Health Care Conference in Boston today. Register here for the live webcast or replay: ir.iovance.com/events/event-…
2
25
3,166
Earlier this week, we shared exciting clinical results in two aggressive forms of advanced soft tissue sarcoma, illustrating the promise of our TIL cell therapy platform to offer meaningful clinical benefit in multiple solid tumor cancers: ir.iovance.com/news-releases…
4
27
1,435